Day

August 11, 2020
Wearable technology designed to treat depression has won a “breakthrough device” designation from the U.S. Food and Drug Administration. The Relivion system, developed by Neurolief, is a non-invasive multi-channel brain neuromodulation technology. It is designed as an additional treatment to pharmaceutical management of major depressive disorder in adults who have not achieved satisfactory improvement from...
Read More

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases